Healthcare provider profile · identity verified

Pamela Hoffman, MD

Internal Medicine · BRIDGEPORT, CT · NPI 1366548778

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	507	22
Trazodone Hcl	Trazodone Hcl	265	36
Levothyroxine Sodium	Levothyroxine Sodium	254	31
Myrbetriq	Mirabegron	224	11
Jardiance	Empagliflozin	216	12
Escitalopram Oxalate	Escitalopram Oxalate	179	20
Furosemide	Furosemide	167	24
Gabapentin	Gabapentin	162	16
Atorvastatin Calcium	Atorvastatin Calcium	150	19
Lisinopril	Lisinopril	122	17
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	118	13
Quetiapine Fumarate	Quetiapine Fumarate	108	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	108	14
Rosuvastatin Calcium	Rosuvastatin Calcium	104	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	102	15
Pravastatin Sodium	Pravastatin Sodium	102	15
Amlodipine Besylate	Amlodipine Besylate	100	15
Memantine Hcl	Memantine Hcl	95	suppressed
Omeprazole	Omeprazole	93	14
Mirtazapine	Mirtazapine	85	14
Metoprolol Succinate	Metoprolol Succinate	83	12
Alendronate Sodium	Alendronate Sodium	80	11
Simvastatin	Simvastatin	76	suppressed
Duloxetine Hcl	Duloxetine Hcl	75	11
Donepezil Hcl	Donepezil Hcl	73	12
Oxycodone Hcl	Oxycodone Hcl	73	suppressed
Linzess	Linaclotide	67	suppressed
Spironolactone	Spironolactone	67	11
Baclofen	Baclofen	63	suppressed
Torsemide	Torsemide	62	suppressed
Methenamine Hippurate	Methenamine Hippurate	60	suppressed
Fluticasone Propionate	Fluticasone Propionate	56	20
Finasteride	Finasteride	52	suppressed
Montelukast Sodium	Montelukast Sodium	49	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	46	suppressed
Sertraline Hcl	Sertraline Hcl	45	12
Farxiga	Dapagliflozin Propanediol	41	suppressed
Metformin Hcl	Metformin Hcl	40	suppressed
Risperidone	Risperidone	40	suppressed
Warfarin Sodium	Warfarin Sodium	40	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	38	suppressed
Divalproex Sodium	Divalproex Sodium	37	suppressed
Lubiprostone	Lubiprostone	37	suppressed
Famotidine	Famotidine	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Losartan Potassium	Losartan Potassium	33	suppressed
Sucralfate	Sucralfate	33	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	suppressed
Potassium Chloride	Potassium Chloride	32	suppressed
Xarelto	Rivaroxaban	31	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	30	16
Alprazolam	Alprazolam	30	suppressed
Ramelteon	Ramelteon	30	suppressed
Albuterol Sulfate	Albuterol Sulfate	29	12
Latanoprost	Latanoprost	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Metformin Hcl Er	Metformin Hcl	28	suppressed
Nystatin	Nystatin	27	suppressed
Methimazole	Methimazole	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Lactulose	Lactulose	25	suppressed
Clobetasol Propionate	Clobetasol Propionate	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Mirabegron Er	Mirabegron	23	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Zonisamide	Zonisamide	21	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	19	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	19	suppressed
Oxcarbazepine	Oxcarbazepine	19	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	18	17
Bupropion Xl	Bupropion Hcl	18	suppressed
Scopolamine	Scopolamine	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Glycopyrrolate	Glycopyrrolate	17	suppressed
Prednisone	Prednisone	17	suppressed
Prolia	Denosumab	17	13
Mesalamine	Mesalamine	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Carvedilol	Carvedilol	15	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	14	suppressed
Fentanyl	Fentanyl	14	suppressed
Naproxen	Naproxen	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Verapamil Hcl	Verapamil Hcl	13	suppressed
Alphagan P	Brimonidine Tartrate	12	suppressed
Anastrozole	Anastrozole	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	12	suppressed
Cyclosporine	Cyclosporine	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Balsalazide Disodium	Balsalazide Disodium	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Nyamyc	Nystatin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error